Indoco Remedies Limited
Indoco Remedies Limited (INDOCO-EQ) live share price today at NSE / BSE
Thu, 17 Sept 2026, 01:41 PM
About INDOCO-EQ
Indoco Remedies Ltd is an established Indian pharmaceutical company engaged in the research, development, manufacture, and marketing of finished dosage formulations and active pharmaceutical ingredients (APIs). Headquartered in Mumbai, Indoco operates through a robust network of manufacturing facilities and R&D centers, catering to both domestic and international markets. The company serves a wide therapeutic spectrum including anti-infectives, respiratory, gastro-intestinal, pain management, and ophthalmology, with a portfolio spanning branded generics and specialty pharmaceuticals.
52 Week Range
Current Signal
red
Open
INR 254.00
High
INR 259.65
Low
INR 251.47
Prev. Close
INR 254.00
Volume
2,88,596
Avg. Volume (7D)
18,68,242
Avg. Volume (10D)
15,22,474
Latest Signal
SellSell Price
INR 242.0
Close Price
INR 241.39
Change
2.89%
Signal Date
2026-09-15
Hold
No
Pattern
Doji
Company Snapshot
| CIN | L85190MH1947PLC005913 |
| Industry | Pharmaceuticals |
| Market Lot | 1 |
| Impact Cost | 0.21% |
| Listing Date | 13 Jan 2005 |
| BC Record Date | RD 04/09/2025 |
| Registered Address | 166 Indoco House, C S T Road, Santacruz (E) |
| Auditor | M/S GOKHALE & SATHE |
Registrar
Board of Directors
Today Share Price
Indoco Remedies Limited
| Particulars | Details |
|---|---|
| Opening Price | INR 254.00 |
| Previous Closing Price | INR 254.00 |
| Volume of Indoco Remedies Limited | 2,88,596 |
| Value of Share | — |
Today NSE Share Price
Indoco Remedies Limited
| Particulars | Details |
|---|---|
| Live Share Price NSE India | INR 254.44 |
| Previous Closing Price | INR 254.00 |
| Open Price | INR 254.00 |
| High | INR 259.65 |
| Low | INR 251.47 |
Today BSE Share Price
Indoco Remedies Limited
| Particulars | Details |
|---|---|
| Live Share Price BSE India | INR 254.44 |
| Previous Closing Price | INR 254.00 |
| Open Price | INR 254.00 |
| High | INR 259.65 |
| Low | INR 251.47 |
Indoco Remedies Limited
Indoco Remedies Ltd is an established Indian pharmaceutical company engaged in the research, development, manufacture, and marketing of finished dosage formulations and active pharmaceutical ingredients (APIs). Headquartered in Mumbai, Indoco operates through a robust network of manufacturing facilities and R&D centers, catering to both domestic and international markets. The company serves a wide therapeutic spectrum including anti-infectives, respiratory, gastro-intestinal, pain management, and ophthalmology, with a portfolio spanning branded generics and specialty pharmaceuticals.
Indoco Remedies has a significant presence across regulated markets such as the United States and Europe, as well as in emerging markets of Asia, Africa, and the CIS region. The company’s growth is supported by a vertically integrated model, continuous investments in quality compliance (with USFDA, UK MHRA, WHO-GMP, and other global approvals), and an established distribution footprint. Indoco’s consistent focus on innovation and product pipeline expansion positions it as a reliable partner for out-licensing and contract manufacturing.
Frequently Asked Questions – StockYaari Stock Page
Every stock page on StockYaari is built to give investors a complete picture of a company before they act on any idea. Below are the most common questions users ask about how this page works, what it shows, and how to make the most of it while researching a company.
Final Thoughts
Taken together, these sections are what make a StockYaari stock page useful for both quick decisions and deeper research. Whether someone is checking a live price during market hours, studying a company's fundamentals before investing for the long term, or simply confirming whether an analyst has an active call on a stock, everything sits in one organised place. New users are encouraged to explore each section at their own pace, since familiarity with the layout makes future research faster and more confident over time.
Track. Analyse. Outperform.
Your performance, our priority.

Platform Performance
(vs NIFTY 50)
Total Return
+24.35%
Outperformance
+12.41%
Accuracy
78%
Join 31,000+ active traders

Ready to unlock premium signals?
Sign in with your mobile number and start trading smarter today.

